ScholarIQanswers from OpenAlex

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1

PaperCitations, authors & open-access status

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 have?

ScholarIQcitation count

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 published?

ScholarIQyear

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has 2006 year in the ScholarIQ index.

What is the open-access status of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

ScholarIQoa status

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 has closed oa status in the ScholarIQ index.

What is the DOI of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

ScholarIQdoi

The DOI for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

What is the PMID of Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

ScholarIQpmid

The PMID for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

What is the OpenAlex record for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1?

ScholarIQopenalex

The OpenAlex for Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial